| Literature DB >> 32708767 |
Ashiqur Rahman1,2, Julia Lin2, Francisco E Jaramillo3, Dennis A Bazylinski4, Clayton Jeffryes2, Si Amar Dahoumane3.
Abstract
Bionanotechnology, the use of biological resources to produce novel, valuable nanomaterials, has witnessed tremendous developments over the past two decades. This eco-friendly and sustainable approach enables the synthesis of numerous, diverse types of useful nanomaterials for many medical, commercial, and scientific applications. Countless reviews describing the biosynthesis of nanomaterials have been published. However, to the best of our knowledge, no review has been exclusively focused on the in vivo biosynthesis of inorganic nanomaterials. Therefore, the present review is dedicated to filling this gap by describing the many different facets of the in vivo biosynthesis of nanoparticles (NPs) using living eukaryotic cells and organisms-more specifically, live plants and living biomass of several species of microalgae, yeast, fungus, mammalian cells, and animals. It also highlights the strengths and weaknesses of the synthesis methodologies and the NP characteristics, bio-applications, and proposed synthesis mechanisms. This comprehensive review also brings attention to enabling a better understanding between the living organisms themselves and the synthesis conditions that allow their exploitation as nanobiotechnological production platforms as these might serve as a robust resource to boost and expand the bio-production and use of desirable, functional inorganic nanomaterials.Entities:
Keywords: bio-applications; bioprocessing; bioreduction; eukaryotes; living cells; nanobiotechnology; nanoparticles; post-processing; sustainability
Mesh:
Substances:
Year: 2020 PMID: 32708767 PMCID: PMC7397067 DOI: 10.3390/molecules25143246
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1(a–g) Production of Au NPs by the roots of the live plants: (a) Phyllanthus fraternus, (b) Portulaca grandiflora, (c) Cicer arietinum, (d) Medicago sativa, (e) Euphorbia hirta, (f) Amaranthus gracilis and (g) Vernonia cinerea. The plants were exposed to 0.0, 0.5, 1.0 and 2.0 mM HAuCl4 aqueous solutions. Some controls contain the culture medium supplemented with cationic gold but not the plant. Adapted from Ref. [60] permission from the Royal Society of Chemistry (RSC). (h–k) Localization of Ag NP within the plant tissues of Brassica juncea: (a) leaf, (b) lower section of outer stem, (c) root and (d) lower section of inner stem. Adapted from Ref. [61] with permission from the RSC.
List of in vivo synthesized, algae-based nanomaterials.
| Nanomaterial | Shape | Size Range (nm) | Precursor(s) or Substrates | Species | Biological Fraction | Synthesis Location | Additional Catalyst(s) or Control Variables | Cultivation Type | Reference |
|---|---|---|---|---|---|---|---|---|---|
| Ag NP | spherical, needle | 168–915 | photons, AgNO3 |
| washed biomass | pH, AgNO3 concentration | [ | ||
| Ag NP | rounded, rectangular | 5–15/ 5–35 | AgNO3 |
| cell-free extract/ live cell | in vitro/ in vivo | oxidoreductive proteins, reducing capacity of biological extracts, incubation time, nitric acid, HCl | Erlenmeyer flask / agar plate | [ |
| Fe-based NP | spherical | 0.6–1.0 | Fe(II)/Fe(III) ions |
| intracellular | Erlenmeyer flask | [ | ||
| Au NP | <20 | Au, HAuCl4 xH2O |
| washed live algal biomass, live algae | Intracellular | pH, time | [ | ||
| Ag NP | spherical | 15–30 | photons, AgNO3 | living cultures | Intracellular | [ | |||
| Au NP | HAuCl4 |
| living cells | within cells, cell outer surface, culture medium | 20 °C, photons | Erlenmeyer flask | [ | ||
| Au NP | spherical | 5.7, 11.3 | HAuCl4 |
| living culture | intracellular (thylakoidal membranes) | Erlenmeyer flask | [ | |
| Ag-Au alloy NP | spherical | photons, AgNO3, HAuCl4·H2O |
| living cells | Intracellular | incubation time | Erlenmeyer flask | [ | |
| Au NP | spherical | 10–10s | HAuCl4 |
| living cultures | Intracellular | Erlenmeyer flask | [ | |
| Ag NP | spherical | 20, 8.2, 8.8 | AgNO3 |
| algae biomass, algal culture | in vivo | [ | ||
| CdS NP | 150–175 |
| live cells | pH, initial Cd concentration, biosorbent dose (biomass | [ | ||||
| Au NP | spherical, triangular, hexagonal, irregular | 3–5 nm, 0–30, 20–50, 100+, 300 | HAuCl4·3H2O |
| Concentration) | Erlenmeyer flask | [ | ||
| Ag NP | spherical | 6–24, 15–60 | AgNO3 |
| alga cell suspension, cell-free filtrate | intracellular, extracellular | [ | ||
| magnetic nanomaterial | FeCl3·6H2O | living culture | [ | ||||||
| Ag NP | 53–72 | AgNO3 |
| algal culture | microwave irradiation, photons | [ | |||
| Au NP | triangular, spherical | 25, 30 | HAuCl4 | algal culture | intracellular | [ | |||
| Au NP | nanorod | 137–209 length, 33–69 diam. | HAuCl4·xH2O |
| biomass | intracellular | [ | ||
| Au NP | spherical, irregular, nanorods | 8–42, 10–30 | HAuCl4·xH2O |
| biomass | extracellular | agar slab, flasks, tub/tank culture | [ | |
| Au NP | spherical, triangular | 10–30 | HAuCl4 |
| living culture | [ | |||
| Au-silica nanocomposite |
| living culture | [ | ||||||
| Ag NP | spherical | ~ 3–8 | photons, AgNO3 | living culture | Erlenmeyer flask | [ | |||
| Ag NP | spherical | ~3–8 | photons, AgNO3 | living culture | Erlenmeyer flask | [ | |||
| Ag NP | spherical | ~2–24 | photons, AgNO3 |
| living culture | quantum efficiency of the cells | Erlenmeyer flask | [ | |
| Ag NP | irregular | n/a | photons, AgNO3 |
| washed cells | quantum efficiency of the cells | Erlenmeyer flask | [ | |
| Cu NP | 15–65 | CuSO4·5H2O |
| living culture | [ | ||||
| Ag NP | 8–20, 12.62 | AgNO3 |
| continuously stirred non-aerated culture assembly | [ | ||||
| Au NP | spherical, triangular | 5–35 | HAuCl4 |
| harvested cells | algal culture chamber | [ | ||
| Pd@Ag core-shell NP | spherical | 5.37–38.98 |
| washed cells | [ | ||||
| Ag NP | spherical | <200 | AgNO3 |
| living culture | Erlenmeyer flask | [ | ||
| biosilica |
| dry biomass | [ | ||||||
| CdSe QD | spherical | 5–6 | Na2SeO3, Cd(NO3)2 |
| intracellular | dosage, pH, reaction temperature, and time | Erlenmeyer flask | [ | |
| CdSe NP | spherical | Na2SeO3, Cd(NO3)2 |
| intracellular | [ |
Factors affecting the in vivo synthesis process.
|
| Produced | Shape | Size | Temp. | pH | Incubation | Illumination | Prec. Conc. | Biomass Weight | Prec. Conc./Biomass | Ref. |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Ag NP | spherical, needle | 168–915 | 20 | 6–9 | 2 d | 300 | 1–5 | 5 (wet) | 0.2–1 | [ |
|
| Au NP | <20 | 6–8 | 3 d | 0.03 | 0.5 (wet) | 0.06 | [ | |||
|
| Ag NP | spherical, | 8.2–20 | 28 ± 2 | 14 d | 45 | 1 | 5 | 0.2 | [ | |
|
| Au NP | spherical, triangular, hexagonal, irregular | 3–300 | 23 ± 1 | 14 d | 25 | 0.1–1 | [ | |||
|
| Ag NP | spherical | 6–60 | 12 h | 27 | 1 | [ | ||||
| Au NP | triangular, spherical | 25–30 | 1 h | 0 | 1 | 0.5 | 2 | [ | |||
|
| Au NP | nanorod | 137–209 (l), 33–69 (d) | 20 | 4.5 | 2 d | 20–30 | 0.04 | [ | ||
|
| Au NP | spherical, irregular, nanorods | 8–30 | 20 | 5–9 | 5 d | 20–30 | 0.003–0.3 | [ | ||
|
| Au NP | spherical, triangular | 10–30 | 18 | 8 | 5 h–8 d | 0.0001–0.5 | [ | |||
|
| Au-silica nanocomposite | 18 | 8 | 2 d | 0.2 | [ | |||||
|
| Ag NP | spherical | 2–24 | 22 ± 1 | 1 d | 69 ± 5 | 0.125–1.250 | [ | |||
|
| Ag NP | irregular | n/a | 22 ± 1 | 1 d | 69 ± 5 | 0.125–1.250 | [ | |||
|
| Cu NP | 15–65 | 6.8–7.7 | 72 h | 50–230 | 0.5 | [ | ||||
|
| Ag NP | 8–20 | 24 ± 2 | 3 d | 54 | 1 | [ | ||||
|
| Au NP | spherical, triangular | 5–35 | 28–29 | 2 d | 1 | 10 | 0.1 | [ | ||
|
| Ag NP | spherical | <200 | 25 | 8–17 d | 70 | 0–0.01 | [ |
Figure 2Post-processing flowchart of in vivo synthesized nanomaterials.
Figure 3(a) Scheme of 2-step procedure for the synthesis of CdSe QDs: first, the added Na2SeO3 precursor enters the cells of Saccharomyces cerevisiae where Se reacts with GSH to give rise to organoselenium compounds; then CdCl2 is added, enters the cells and reacts with organoselenium compounds to yield CdSe QDs by reacting. (b) Fluorescence images of S. cerevisiae cells that produce intracellular CdSe QDs via the 2-step procedure described in (a). Adapted from Ref. [65] with permission from Wiley.
Figure 4Schematic of administration of [Ag(GSH)]+ complex solution to mice bearing tumor xenograft, followed by the subsequent formation of Ag NCs that are exploited in both NIR-fluorescence imaging and treatment of cancer. Reprinted from Ref. [165] under creative common license agreement.